Personalized Cancer Medicine Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Personalized Cancer Vaccines
1.2.4 Other
1.3 Market by Application
1.3.1 Global Personalized Cancer Medicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Medicine Market Perspective (2017-2028)
2.2 Personalized Cancer Medicine Growth Trends by Region
2.2.1 Personalized Cancer Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2017-2022)
2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2023-2028)
2.3 Personalized Cancer Medicine Market Dynamics
2.3.1 Personalized Cancer Medicine Industry Trends
2.3.2 Personalized Cancer Medicine Market Drivers
2.3.3 Personalized Cancer Medicine Market Challenges
2.3.4 Personalized Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Medicine Players by Revenue
3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2017-2022)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue
3.4 Global Personalized Cancer Medicine Market Concentration Ratio
3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2021
3.5 Personalized Cancer Medicine Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Medicine Product Solution and Service
3.7 Date of Enter into Personalized Cancer Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Medicine Breakdown Data by Type
4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2017-2022)
4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2023-2028)
5 Personalized Cancer Medicine Breakdown Data by Application
5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2017-2022)
5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Personalized Cancer Medicine Market Size (2017-2028)
6.2 North America Personalized Cancer Medicine Market Size by Country (2017-2022)
6.3 North America Personalized Cancer Medicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Personalized Cancer Medicine Market Size (2017-2028)
7.2 Europe Personalized Cancer Medicine Market Size by Country (2017-2022)
7.3 Europe Personalized Cancer Medicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Medicine Market Size (2017-2028)
8.2 Asia-Pacific Personalized Cancer Medicine Market Size by Country (2017-2022)
8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Personalized Cancer Medicine Market Size (2017-2028)
9.2 Latin America Personalized Cancer Medicine Market Size by Country (2017-2022)
9.3 Latin America Personalized Cancer Medicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Medicine Market Size (2017-2028)
10.2 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2017-2022)
10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Personalized Cancer Medicine Introduction
11.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Personalized Cancer Medicine Introduction
11.2.4 Merck Revenue in Personalized Cancer Medicine Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Cancer Medicine Introduction
11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Personalized Cancer Medicine Introduction
11.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2017-2022)
11.4.5 Amgen Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Personalized Cancer Medicine Introduction
11.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2017-2022)
11.5.5 Celgene Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Personalized Cancer Medicine Introduction
11.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2017-2022)
11.6.5 Bayer Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Personalized Cancer Medicine Introduction
11.7.4 Roche Revenue in Personalized Cancer Medicine Business (2017-2022)
11.7.5 Roche Recent Development
11.8 Astellas
11.8.1 Astellas Company Detail
11.8.2 Astellas Business Overview
11.8.3 Astellas Personalized Cancer Medicine Introduction
11.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2017-2022)
11.8.5 Astellas Recent Development
11.9 Astrazeneca
11.9.1 Astrazeneca Company Detail
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Personalized Cancer Medicine Introduction
11.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2017-2022)
11.9.5 Astrazeneca Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2017-2022)
11.10.5 Johnson & Johnson Recent Development
11.11 Agilent
11.11.1 Agilent Company Detail
11.11.2 Agilent Business Overview
11.11.3 Agilent Personalized Cancer Medicine Introduction
11.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2017-2022)
11.11.5 Agilent Recent Development
11.12 Takeda
11.12.1 Takeda Company Detail
11.12.2 Takeda Business Overview
11.12.3 Takeda Personalized Cancer Medicine Introduction
11.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2017-2022)
11.12.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Personalized Cancer Vaccines
Table 4. Key Players of Other
Table 5. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Personalized Cancer Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Personalized Cancer Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Personalized Cancer Medicine Market Share by Region (2017-2022)
Table 9. Global Personalized Cancer Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Personalized Cancer Medicine Market Share by Region (2023-2028)
Table 11. Personalized Cancer Medicine Market Trends
Table 12. Personalized Cancer Medicine Market Drivers
Table 13. Personalized Cancer Medicine Market Challenges
Table 14. Personalized Cancer Medicine Market Restraints
Table 15. Global Personalized Cancer Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Personalized Cancer Medicine Market Share by Players (2017-2022)
Table 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2021)
Table 18. Ranking of Global Top Personalized Cancer Medicine Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Personalized Cancer Medicine Product Solution and Service
Table 22. Date of Enter into Personalized Cancer Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Personalized Cancer Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Personalized Cancer Medicine Revenue Market Share by Type (2017-2022)
Table 26. Global Personalized Cancer Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Personalized Cancer Medicine Revenue Market Share by Type (2023-2028)
Table 28. Global Personalized Cancer Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Personalized Cancer Medicine Revenue Market Share by Application (2017-2022)
Table 30. Global Personalized Cancer Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Personalized Cancer Medicine Revenue Market Share by Application (2023-2028)
Table 32. North America Personalized Cancer Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Personalized Cancer Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Personalized Cancer Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Personalized Cancer Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Personalized Cancer Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Personalized Cancer Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 42. Abbott Company Detail
Table 43. Abbott Business Overview
Table 44. Abbott Personalized Cancer Medicine Product
Table 45. Abbott Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 46. Abbott Recent Development
Table 47. Merck Company Detail
Table 48. Merck Business Overview
Table 49. Merck Personalized Cancer Medicine Product
Table 50. Merck Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Novartis Company Detail
Table 53. Novartis Business Overview
Table 54. Novartis Personalized Cancer Medicine Product
Table 55. Novartis Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. Amgen Company Detail
Table 58. Amgen Business Overview
Table 59. Amgen Personalized Cancer Medicine Product
Table 60. Amgen Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 61. Amgen Recent Development
Table 62. Celgene Company Detail
Table 63. Celgene Business Overview
Table 64. Celgene Personalized Cancer Medicine Product
Table 65. Celgene Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 66. Celgene Recent Development
Table 67. Bayer Company Detail
Table 68. Bayer Business Overview
Table 69. Bayer Personalized Cancer Medicine Product
Table 70. Bayer Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Roche Company Detail
Table 73. Roche Business Overview
Table 74. Roche Personalized Cancer Medicine Product
Table 75. Roche Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Astellas Company Detail
Table 78. Astellas Business Overview
Table 79. Astellas Personalized Cancer Medicine Product
Table 80. Astellas Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 81. Astellas Recent Development
Table 82. Astrazeneca Company Detail
Table 83. Astrazeneca Business Overview
Table 84. Astrazeneca Personalized Cancer Medicine Product
Table 85. Astrazeneca Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 86. Astrazeneca Recent Development
Table 87. Johnson & Johnson Company Detail
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Personalized Cancer Medicine Product
Table 90. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. Agilent Company Detail
Table 93. Agilent Business Overview
Table 94. Agilent Personalized Cancer MedicineProduct
Table 95. Agilent Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 96. Agilent Recent Development
Table 97. Takeda Company Detail
Table 98. Takeda Business Overview
Table 99. Takeda Personalized Cancer MedicineProduct
Table 100. Takeda Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million)
Table 101. Takeda Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Medicine Market Share by Type: 2021 VS 2028
Figure 2. Monoclonal Antibodies Features
Figure 3. Personalized Cancer Vaccines Features
Figure 4. Other Features
Figure 5. Global Personalized Cancer Medicine Market Share by Application in 2021 & 2028
Figure 6. Breast Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Chronic Myeloid Leukaemia Case Studies
Figure 9. Bowel Cancer Case Studies
Figure 10. Other Cancer Case Studies
Figure 11. Personalized Cancer Medicine Report Years Considered
Figure 12. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Personalized Cancer Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Personalized Cancer Medicine Market Share by Region: 2021 VS 2028
Figure 15. Global Personalized Cancer Medicine Market Share by Players in 2021
Figure 16. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2021
Figure 18. North America Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Personalized Cancer Medicine Market Share by Country (2017-2028)
Figure 20. United States Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Personalized Cancer Medicine Market Share by Country (2017-2028)
Figure 24. Germany Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Personalized Cancer Medicine Market Share by Region (2017-2028)
Figure 32. China Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Personalized Cancer Medicine Market Share by Country (2017-2028)
Figure 40. Mexico Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Personalized Cancer Medicine Market Share by Country (2017-2028)
Figure 44. Turkey Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 47. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 48. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 49. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 50. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 51. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 52. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 53. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 54. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 55. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 56. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 57. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Industry Market Size
